A patient with myasthenia gravis presents with respiratory insufficiency and difficulty swallowing. Which nursing intervention is the highest priority to prevent complications?

B) Elevate the head of the bed to 30 degrees to improve ventilation.

A) Initiate a low-sodium diet to reduce fluid retention.

B) Elevate the head of the bed to 30 degrees to improve ventilation.

C) Educate the patient about energy conservation techniques.

D) Administer anticholinesterase medications as prescribed.

A patient with myasthenia gravis is suspected of experiencing a myasthenic crisis. Which of the following interventions should the nurse prioritize to address the patient's current respiratory status?

A) Initiate non-invasive ventilation support

B) Administer thickened liquids to prevent aspiration

C) Perform hourly neurological checks

D) Prepare for immediate intubation and mechanical ventilation

A patient with myasthenia gravis is experiencing respiratory acidosis despite non-invasive ventilation and supplemental oxygen. Which nursing intervention should be prioritized to address the patient's current respiratory status?

B) Prepare the patient for potential intubation and mechanical ventilation.

A) Encourage the patient to perform deep breathing exercises to improve ventilation.

B) Prepare the patient for potential intubation and mechanical ventilation.

C) Administer a bronchodilator to relieve bronchospasm and improve airflow.

D) Increase the rate of supplemental oxygen to enhance oxygen saturation levels.

A patient with myasthenia gravis is experiencing respiratory acidosis and hypoxemia despite non-invasive ventilation. The clinical team is considering plasmapheresis if her condition does not improve with IVIG therapy. As the nurse, which of the following assessments is most crucial to monitor for signs of respiratory failure requiring escalation of care to invasive ventilation?

A) Monitoring for increased respiratory rate and use of accessory muscles

B) Assessing for signs of aspiration during meals

C) Observing for changes in blood pressure and heart rate

D) Evaluating the effectiveness of thickened liquids in preventing aspiration

A patient with exacerbation of myasthenia gravis is undergoing plasmapheresis. Which nursing intervention is most critical to prevent complications during the procedure?

C) Monitor electrolyte levels and adjust fluids accordingly

A) Monitor for signs of infection

B) Assess for muscle strength improvement

C) Monitor electrolyte levels and adjust fluids accordingly

D) Encourage deep breathing exercises

A patient with myasthenia gravis is exhibiting increased muscle weakness, diplopia, and respiratory acidosis despite treatment with IVIG. Which priority nursing intervention should be implemented to address the patient's deteriorating respiratory status?

D) Notify the physician to consider intubation and mechanical ventilation.

A) Administer supplemental oxygen to maintain oxygen saturation above 92%.

B) Prepare the patient for plasmapheresis to reduce circulating antibodies.

C) Elevate the head of the bed to 45 degrees to facilitate respiratory effort.

D) Notify the physician to consider intubation and mechanical ventilation.

A patient with myasthenia gravis undergoing plasmapheresis presents with autonomic instability and hypokalemia. Which nursing intervention should be prioritized to address the patient's current condition?

B) Administer potassium supplementation as ordered and monitor serum levels.

A) Increase the frequency of blood pressure monitoring to every 15 minutes.

B) Administer potassium supplementation as ordered and monitor serum levels.

C) Prepare for intubation due to potential respiratory failure.

D) Initiate a fluid restriction protocol to manage hypertension.

A patient with myasthenia gravis undergoing plasmapheresis is showing signs of autonomic instability, including erratic heart rates and fluctuating blood pressures, along with hypokalemia. What is the nurse's priority action to address the patient's current condition?

B) Initiate potassium supplementation to correct the hypokalemia.

A) Administer a prescribed beta-blocker to stabilize the heart rate.

B) Initiate potassium supplementation to correct the hypokalemia.

C) Increase the patient's oxygen flow to improve respiratory status.

D) Elevate the head of the bed to 45 degrees to promote hemodynamic stability.

A patient with myasthenia gravis is experiencing increased muscle cramps, generalized weakness, and mild ptosis. The healthcare team identified hypokalemia with a potassium level of 3.2 mmol/L. Despite initial interventions, the patient's symptoms persist, and her cardiac rhythm is unstable. Which nursing intervention should be prioritized to address the current situation?

B) Administer oral potassium supplements to correct the electrolyte imbalance.

A) Increase the frequency of anticholinesterase medication to manage myasthenic symptoms.

B) Administer oral potassium supplements to correct the electrolyte imbalance.

C) Initiate continuous cardiac monitoring and prepare for potential arrhythmias.

D) Assess respiratory function and prepare for possible respiratory support.

A patient with myasthenia gravis presents with increased muscle cramps, generalized weakness, and hypokalemia. Despite potassium supplementation, her serum potassium remains low. Which nursing intervention is the most appropriate to address her current symptoms and prevent further complications?

C) Collaborate with the healthcare provider to adjust the anticholinesterase medication dosage.

A) Increase the frequency of potassium level monitoring to every 4 hours.

B) Administer calcium gluconate to counteract the muscle weakness.

C) Collaborate with the healthcare provider to adjust the anticholinesterase medication dosage.

D) Initiate continuous cardiac monitoring to detect potential arrhythmias.

myasthenia gravis - Nursing Case Study

Pathophysiology

• Primary mechanism: Myasthenia gravis is primarily caused by an autoimmune attack on acetylcholine receptors at the neuromuscular junction, leading to impaired nerve signal transmission to muscles, which results in muscle weakness and fatigue.

• Secondary mechanism: The presence of antibodies against acetylcholine receptors accelerates receptor degradation and reduces receptor density, further decreasing the efficiency of neuromuscular transmission.

• Key complication: Reduced communication between nerves and muscles can lead to severe muscle weakness, including respiratory muscles, posing a risk for respiratory failure if not managed appropriately.

Patient Profile

Demographics:

42-year-old female, school teacher

History:

• Key past medical history: Diagnosed with myasthenia gravis two years ago, hypertension

• Current medications: Pyridostigmine, Lisinopril, Prednisone

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing muscle weakness and fatigue

• Key symptoms: Ptosis, diplopia, difficulty swallowing, shortness of breath, generalized muscle weakness

• Vital signs: Blood pressure 145/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

Two days after her initial presentation, the patient experiences a noticeable decline in her respiratory function, prompting a reassessment of her condition. The patient reports an escalation in shortness of breath and an increased difficulty with both inhalation and exhalation. On examination, her respiratory rate has increased to 28 breaths per minute, with shallow breathing patterns noted. Auscultation reveals diminished breath sounds at the lung bases, and accessory muscle use is evident. Her oxygen saturation has decreased to 88% on room air, necessitating the initiation of supplemental oxygen.

In addition to her respiratory symptoms, the patient also reports increased difficulty with swallowing and experiences frequent choking episodes during meals. A bedside swallow evaluation indicates a high risk of aspiration, prompting a shift to a modified diet with thickened liquids. Neurological examination reveals pronounced ptosis and further deterioration in muscle strength, especially in the proximal muscles of the limbs, with a new finding of neck flexor weakness.

Given these changes, the clinical team suspects the possibility of a myasthenic crisis, a severe exacerbation of myasthenia gravis characterized by worsening muscle weakness and respiratory insufficiency. Urgent assessment of arterial blood gases shows a pH of 7.31, PaCO2 of 55 mmHg, and PaO2 of 65 mmHg, indicative of respiratory acidosis and hypoxemia. This clinical picture necessitates immediate intervention with non-invasive ventilation support and consideration for intravenous immunoglobulin (IVIG) or plasmapheresis to address the underlying exacerbation of her myasthenia gravis. The care plan is adjusted to closely monitor her respiratory status and prepare for potential escalation to invasive mechanical ventilation if her condition does not improve.

Section 2

Response to Interventions:

Following the initiation of non-invasive ventilation, the patient's respiratory status demonstrates mild improvement, with oxygen saturation rising to 92% on supplemental oxygen. However, her respiratory rate remains elevated at 26 breaths per minute, and she continues to exhibit shallow breathing patterns with accessory muscle use. Despite these interventions, the patient's arterial blood gas analysis shows only slight improvement, with a pH of 7.34, PaCO2 of 50 mmHg, and PaO2 of 70 mmHg, indicating persistent respiratory acidosis and hypoxemia. The clinical team decides to proceed with intravenous immunoglobulin (IVIG) therapy, aiming to decrease the autoimmune attack on her neuromuscular junctions.

Concurrently, the patient's swallowing difficulties necessitate a collaborative approach with the speech and language therapy team, who implement a strict regimen of thickened liquids and pureed diet to mitigate the risk of aspiration. Despite these precautions, the patient experiences a mild aspiration event, leading to a transient drop in oxygen saturation, which quickly resolves with suctioning and increased supplemental oxygen. This incident underscores the importance of ongoing vigilance and the need for potential escalation to invasive ventilation if her respiratory function does not stabilize.

As the team monitors her response to IVIG, they remain alert for any signs of further deterioration, such as increased respiratory distress or decreased muscle strength. The interdisciplinary team, including neurology, pulmonology, and critical care, convenes to discuss the next steps, considering the possibility of plasmapheresis if IVIG proves insufficient. The nursing staff plays a critical role in continuous assessment, focusing on the patient's respiratory status, swallowing ability, and overall muscle strength to promptly identify any changes that may necessitate further intervention. Through diligent monitoring and coordinated care, the team aims to navigate this potential myasthenic crisis and guide the patient toward stability.

Section 3

New Complications:

As the patient continues under close observation, the nursing team notes a subtle yet concerning change in her neurologic status. Over the next 24 hours, she begins to exhibit increased muscle weakness, particularly in her proximal muscle groups. Her grip strength weakens, and she struggles to raise her arms above her head, indicating potential exacerbation of her myasthenia gravis. These changes coincide with a new development of fluctuating palpebral ptosis and diplopia, suggesting further neuromuscular compromise. The patient's speech becomes more slurred, and she reports increased fatigue, which alarms the clinical team given her tenuous respiratory status.

Laboratory results show a rising trend in creatine kinase levels, now measuring 250 U/L, suggesting some muscle breakdown. Despite the administration of IVIG, the patient demonstrates minimal improvement, raising concerns about the adequacy of this treatment alone. Repeat arterial blood gas analysis reveals persistent respiratory acidosis with a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 68 mmHg, indicating that her respiratory function has not significantly improved and could be deteriorating. Given these findings, the interdisciplinary team decides to expedite the initiation of plasmapheresis to more aggressively remove circulating antibodies, hoping to halt the progression of her symptoms.

The nursing staff, integral to this transition, ensures meticulous monitoring of her vital signs, particularly focusing on respiratory rate, effort, and oxygen saturation, while also assessing for any signs of autonomic instability. The team also promptly involves the dietitian to reassess her nutritional needs given her increased energy expenditure and muscle weakness. As they implement these next steps, they remain vigilant for potential complications associated with plasmapheresis, such as electrolyte imbalances and hemodynamic instability, ready to intervene promptly to support the patient through this critical phase of her treatment journey.

Section 4

New Complications:

Over the next 48 hours, the patient begins to exhibit signs of autonomic instability, a potential complication of both myasthenia gravis and plasmapheresis. Her heart rate becomes increasingly erratic, alternating between periods of tachycardia and bradycardia, with her heart rate ranging from 50 to 110 beats per minute. The nursing team also notes fluctuating blood pressures, with systolic readings varying from 90 to 160 mmHg, indicating a lack of sympathetic tone regulation. These cardiovascular changes raise concerns about the patient's hemodynamic stability, prompting the team to initiate continuous cardiac monitoring and consult with cardiology for further evaluation.

Concurrently, new laboratory results reveal a significant drop in serum potassium levels, now measuring at 3.0 mmol/L, likely due to the plasmapheresis procedure. This hypokalemia may contribute to both the observed muscle weakness and cardiac irregularities, necessitating urgent electrolyte replacement therapy. In response, the interdisciplinary team collaborates to adjust her IV fluids to include potassium supplementation, while carefully monitoring her cardiac rhythm and muscle strength for any signs of improvement or further deterioration.

Despite these challenges, there is a slight improvement in her respiratory function, with a recent arterial blood gas showing a pH of 7.35, PaCO2 of 48 mmHg, and PaO2 of 72 mmHg. Her respiratory rate stabilizes at 20 breaths per minute, and her oxygen saturation consistently remains above 92% with supplemental oxygen. This suggests a partial response to the plasmapheresis, providing a glimmer of hope amidst the complex clinical picture. The team remains cautiously optimistic but vigilant, understanding the critical importance of balancing her cardiovascular, respiratory, and neuromuscular needs as they continue to navigate the complexities of her condition.

Section 5

As the patient's condition evolves, the healthcare team continues to closely monitor her response to the implemented interventions. Despite the initial improvement in respiratory function, new complications arise as her condition progresses. On the third day, the patient begins to complain of increased muscle cramps and generalized weakness, which are accompanied by a return of mild ptosis and dysphagia. The nursing team conducts a thorough assessment, noting that her grip strength has decreased and the muscle tone in her limbs is diminished. These developments suggest a potential exacerbation of her myasthenia gravis symptoms, potentially triggered by the ongoing hypokalemia and its effects on neuromuscular transmission.

In light of these changes, the interdisciplinary team swiftly reassesses her electrolyte management strategy. Repeated laboratory tests reveal that, despite the potassium supplementation, her serum potassium level remains slightly below the normal range at 3.2 mmol/L. The decision is made to increase the potassium concentration in her IV fluids and to initiate oral potassium supplements, with the aim of more effectively correcting the electrolyte imbalance. Additionally, the team considers the possibility of adjusting her anticholinesterase medication regimen, as the current dosage may need to be reevaluated in the context of her fluctuating symptoms and concurrent therapies.

The patient's cardiac rhythm continues to be unstable, with telemetry showing occasional premature ventricular contractions alongside the previously noted variations in heart rate and blood pressure. The cardiology consult recommends further investigation with an echocardiogram to assess cardiac function and any underlying structural abnormalities. Meanwhile, the care team remains vigilant, prioritizing a multifaceted approach that encompasses electrolyte correction, neuromuscular symptom management, and cardiovascular stability. This comprehensive strategy aims to mitigate the patient's current complications while setting the stage for more targeted and effective interventions as her clinical picture continues to unfold.